Oct 15, 2026 07:01AM
Oct 15, 2026 07:00AM
Aug 11, 2026 03:35PM
Aug 11, 2026 03:35PM
Aug 3, 2026 07:00AM
May 18, 2026 08:02AM
May 18, 2026 08:00AM Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 4, 2026 07:00AM
Mar 24, 2026 09:50AM
Mar 23, 2026 07:30AM
Mar 23, 2026 07:30AM
Mar 23, 2026 07:30AM
Feb 17, 2026 07:00AM
Feb 9, 2026 08:00AM Krystal Biotech receives FDA RMAT designation for KB707 lung cancer therapy
Feb 9, 2026 08:00AM
Jan 9, 2026 09:20AM
Jan 9, 2026 06:59AM
Jan 9, 2026 03:13AM
Jan 8, 2026 04:01PM
Jan 8, 2026 04:01PM
Nov 3, 2025 07:00AM Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
Oct 17, 2025 05:50AM
Oct 14, 2025 08:03AM
Oct 14, 2025 08:00AM
Sep 16, 2025 06:53AM
Sep 15, 2025 02:20PM
Sep 15, 2025 08:00AM
Sep 15, 2025 08:00AM Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
Aug 22, 2025 07:57AM
Aug 22, 2025 06:53AM
Aug 21, 2025 12:14PM
Aug 21, 2025 12:11PM
Aug 4, 2025 07:00AM
Jul 25, 2025 09:01AM
Jul 25, 2025 09:00AM Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 9, 2025 07:04AM
Jul 9, 2025 07:00AM
Jun 24, 2025 07:00AM
Jun 3, 2025 08:00AM
May 7, 2025 08:00AM Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
May 6, 2025 08:00AM
Apr 28, 2025 07:05AM
Apr 28, 2025 07:00AM
Apr 24, 2025 08:00AM
Apr 17, 2025 08:00AM
Apr 7, 2025 04:30PM
Apr 7, 2025 04:30PM Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
Feb 28, 2025 07:45AM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All